“… , This situation creates additional costs in production and prolongs the preprocessing time in preparation for production. Additionally, it is difficult to obtain large amounts of cells because cell proliferation is limited by the available surface area. ,,, Since it is known that primary cultures and diploid cell lines retain their adherent character and have limited adaptability to suspended conditions, they are produced adherently in viral vaccine production, either using microcarriers or in packed-bed bioreactors (such as iCellis) where other suitable support materials are used. , Cells with suspension character have advantages such as ease of scale-up since they are not dependent on any surface, less labor required, growth is limited only by the cell concentration in the nutrient medium, and the cellular microenvironment in the production environment is more homogeneous. , However, as mentioned, since almost all of the expressional platforms used in vaccine production show adherent character, if the use of suspension cultures is aimed in production, the cellular substrates must be adapted to the suspension growth condition. , This adaptation is possible by culturing adherent cells in dynamic systems, using serum-free nutrient media specifically developed for the cell line, or applying both methods simultaneously. ,,, In this way, very high success can be achieved in continuous cell lines. ,, However, since the cellular character changes greatly during adaptation, it must be constantly checked that this suspended culture developed by cell engineering synthesizes the vaccine material in sufficient quantities and in a suitable form for industrial use. Additionally, the safety properties of adapted cells, such as tumorigenicity, should also be re-evaluated and checked. ,, The main disadvantage of suspension cultures is the need for cell-retention devices in case of any nutrient media change or washing process during production …”